Ascletis Pharma Inc.
1672
Peringkat dalam Saham
#10492
Ascletis Pharma Inc., a biotechnology company, engages in the research and... Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People’s Republic of China.
Harga Saham
$0.74836845
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$785.53M
Perubahan (1 hari)
1.12%
Perubahan (1 tahun)
-38.66%
Negara
CN
Perdagangan Ascletis Pharma Inc. (1672)
Kategori
Healthcare
Kapitalisasi pasar dari Ascletis Pharma Inc.(1672)
Kapitalisasi Pasar: $785.53M
Per October 2026, Ascletis Pharma Inc. memiliki kapitalisasi pasar sebesar $785.53M. Ini menjadikan Ascletis Pharma Inc. sebagai perusahaan 10492nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Ascletis Pharma Inc. dari 2019 hingga 2026
1672 dibandingkan dengan 5 teratas stocks paling populer
